Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025

Rhea-AI Summary

Accuray (NASDAQ: ARAY) has announced it will release its second quarter fiscal 2025 financial results on February 5, 2025. The company will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on the same day to discuss the results for the period ended December 31, 2024.

Investors can access the conference call via telephone at (833) 316-0563 (USA) or (412) 317-5747 (international). A replay will be available for one week at 1-877-344-7529 (USA) or 1-412-317-0088 (international) using conference ID 8496951. Additionally, a live webcast will be available through the company's Investor Relations website, with a replay accessible until the third quarter fiscal 2025 results announcement.

News Market Reaction – ARAY

+0.44%

1 alert

+0.44% News Effect

On the day this news was published, ARAY gained 0.44%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MADISON, Wis., Jan. 22, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2025, ended December 31, 2024, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on February 5, 2025.

The conference call dial-in numbers are (833) 316-0563 (USA) or (412) 317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is 1-877-344-7529 (USA) or 1-412-317-0088 (international), conference ID: 8496951.

A live webcast of the call will also be available from the Investor Relations section of the company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the third quarter of fiscal 2025.

About Accuray
Accuray Incorporated (Nasdaq: ARAY) is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor Contact
Aman Patel, CFA
Investor Relations, ICR Healthcare
+1 (443) 450-4191
aman.patel@westwicke.com

Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-second-quarter-fiscal-2025-financial-results-on-february-5-2025-302357164.html

SOURCE Accuray Incorporated

FAQ

When will Accuray (ARAY) report Q2 2025 earnings?

Accuray will report its second quarter fiscal 2025 financial results on February 5, 2025, during a conference call at 1:30 p.m. PT/4:30 p.m. ET.

How can investors access Accuray's (ARAY) Q2 2025 earnings call?

Investors can access the call via telephone at (833) 316-0563 (USA) or (412) 317-5747 (international), or through a live webcast on the company's Investor Relations website.

What is the replay information for Accuray's (ARAY) Q2 2025 earnings call?

The replay will be available for one week at 1-877-344-7529 (USA) or 1-412-317-0088 (international) with conference ID 8496951.

What period does Accuray's (ARAY) Q2 2025 earnings report cover?

The earnings report covers the second quarter of fiscal year 2025, which ended December 31, 2024.